Together, three representative compounds ( Quercetin, Luteolin and Baicalein) of HD–SB could bind well to four core targets of HCC (P53, CDK2, XPO1 and APP), all of which could play key roles in the treatment of HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.